Trial of NanoPac Focal Therapy for Prostate Cancer

NCT04221828 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of enrollment

Conditions

Prostate Cancer
Prostate Adenocarcinoma
Prostate Cancer Adenocarcinoma
Prostatic Neoplasm
Urogenital Neoplasms
Genital Neoplasms, Male
Localized Cancer

Interventions

DRUG: NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension

Sponsor

NanOlogy, LLC

Collaborators

[object Object]